Klp Kapitalforvaltning As Apellis Pharmaceuticals, Inc. Call Options Transaction History
Klp Kapitalforvaltning As
- $20.6 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
304Shares Held
110MCall Options Held
3.88MPut Options Held
1.17M-
Avoro Capital Advisors LLC New York, NY12.2MShares$336 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$327 Million14.88% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$324 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$276 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$159 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.02B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...